Table 1.
Pretreatment laboratory characteristics of the patients
Complete blood counts | Median | Range |
---|---|---|
| ||
Hemoglobin, g/dL | 8.7 | 4.7–13.4 |
WBC, ×103/μL | 4 | 1–23.1 |
High-risk+ n= (%) | 4 (23.5) | |
Low-intermediate-risk+ n= (%) | 13 (76.5) | |
Platelet, ×103/μ | 21 | 4–209 |
LCirculating blasts*, % | 38 | 0–100% |
| ||
Fibrinogen level, g/L | 149.5 | 73–505 |
Patients with Sanz high risk (WBC >/= 10 ×103/μ) versus low-intermediate risk (WBC <10 ×103/μL).
Data missing for 4 patients.